Fenofibrate 145 mg Tablets

Fenofibrate 145 mg Tablets
Product Description

Fenofibrate Ethypharm 145 mg is a lipid-lowering medication designed to support the management of dyslipidaemia and reduce cardiovascular risk. It is indicated as an adjunct to diet and lifestyle modifications for the treatment of severe hypertriglyceridaemia and mixed hyperlipidaemia. The formulation utilizes advanced nanoparticle technology to enhance bioavailability and ensure consistent absorption, independent of food intake. With convenient once-daily dosing and a simple administration regimen, it supports patient adherence and effective long-term management. This product can also be used in combination with statins in high-risk patients when lipid levels are not adequately controlled.

Read more Show less

Ethypharm

  • Country/Region:
    France
  • Founded:
    1977
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
  • Active substance: Fenofibrate
  • Pharmaceutical form: Tablets
  • Strength: 145 mg
  • Pack size: 30 tablets
  • Indications:
    • Treatment of severe hypertriglyceridaemia with or without low HDL-cholesterol
    • Mixed hyperlipidaemia when statins are contraindicated or not tolerated
    • Mixed hyperlipidaemia in high cardiovascular risk patients in combination with statins
  • Once-daily oral administration
  • Can be taken with or without food
  • Nanoparticle technology to improve bioavailability
  • Selling Points
    Cardiovascular Health;
  • Effective management of triglycerides and cholesterol levels
  • Proven reduction of cardiovascular risk factors
  • Once-daily dosing for improved convenience
  • No food restrictions (flexible administration)
  • Enhanced bioavailability with nanoparticle formulation
  • Suitable for combination therapy with statins
  • Supports long-term patient adherence
  • Model
    Fenofibrate 145 mg
  • Supplied from
    France
  • Measured In
    milligram
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Ethypharm

    • Country/Region:
      France
    • Founded:
      1977
    • On CPHI since:
      2015
    • Certificates:
      4
    • Employees:
      1000 - 4999
    Company types
    Contract Service
    Distributor/Import Export
    Manufacturer/Innovator
    Pharmaceutical company
    Primary activities
    Contract Manufacturer
    Custom Manufacturing/Custom Synthesis
    Pharmaceutical Company (innovator finished products)
    View company profile

    More Products from Ethypharm (62)

    • Clobazam Oral Suspension

      Product Clobazam Oral Suspension

      Clobazam Oral Suspension is a benzodiazepine indicated as adjunctive therapy in epilepsy when standard treatments are insufficient. It offers flexible dosing and is suitable for patients who require a liquid formulation, including paediatric populations. Available in two strengths and multiple bottle sizes...
    • Colistimethate Sodium

      Product Colistimethate Sodium

      Treatment of serious infections due to selectedaerobic Gram-negative pathogens
    • Dexmedetomidine Hydrochloride

      Product Dexmedetomidine Hydrochloride

      Light sedation before procedures and at ICU
    • Ephedrine Hydrochloride 30 mg/ml

      Product Ephedrine Hydrochloride 30 mg/ml

      Reversal of hypotension from spinal or epidural anaesthesia
    • Esomeprazole Gastro-resistant Capsules

      Product Esomeprazole Gastro-resistant Capsules

      Ventra® is an esomeprazole-based gastro-resistant capsule designed for effective acid management and long-lasting gastric protection. Available in 20 mg and 40 mg strengths, it utilizes advanced microgranule technology to ensure controlled and sustained drug release, improving absorption and reducing varia...
    • Everolimus Tablet

      Product Everolimus Tablet

      Advanced breast cancer
    • Fentanyl Citrate 50 μg/ml

      Product Fentanyl Citrate 50 μg/ml

      Analgesia for short surgical procedures at lowdoses.Analgesia with assisted ventilation at high doses.Treatment of severe pain
    • Fentanyl Sublingual tablet

      Product Fentanyl Sublingual tablet

      Breakthrough pain in opioid therapy for chronic cancer pain
    • Glycopyrronium Bromide 200 μg/ml

      Product Glycopyrronium Bromide 200 μg/ml

      To reduce salivary, tracheobronchial and pharyngeal secretion
    • Ibuprofen Bag

      Product Ibuprofen Bag

      Short-term symptomatic treatment of acute moderate pain
    • Levetiracetam 100 mg/mL

      Product Levetiracetam 100 mg/mL

      Mono- and adjunctive therapy of epilepsy
    • Levobupivacaine Solution for Injection/Infusion

      Product Levobupivacaine Solution for Injection/Infusion

      Levobupivacaine is a long-acting local anaesthetic used for regional anaesthesia and pain management. It provides effective anaesthesia and analgesia across a wide range of clinical settings, including surgery and labour. With a similar efficacy profile to bupivacaine but lower cardiovascular and CNS toxic...
    show all 62 other products

    Ethypharm resources (1)